5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 47.97▲ | 48.09▲ | 47.80▲ | 47.54▲ | 43.21▲ |
MA10 | 47.92▲ | 47.56▲ | 47.88▲ | 46.55▲ | 39.86▲ |
MA20 | 48.07▲ | 47.81▲ | 48.23▼ | 42.93▲ | 35.64▲ |
MA50 | 47.58▲ | 47.92▲ | 47.61▲ | 38.88▲ | 33.90▲ |
MA100 | 47.78▲ | 47.40▲ | 44.90▲ | 34.46▲ | 27.23▲ |
MA200 | 48.31▼ | 44.51▲ | 41.65▲ | 31.80▲ | 20.05▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.027▼ | 0.072▲ | -0.085▼ | 0.377▲ | 1.513▲ |
RSI | 59.488▲ | 52.484▲ | 52.095▲ | 68.824▲ | 71.996▲ |
STOCH | 54.608 | 70.373 | 39.330 | 70.638 | 82.853▲ |
WILL %R | -17.000▲ | -30.707 | -54.509 | -20.735▲ | -12.113▲ |
CCI | 90.757 | 64.222 | -18.729 | 71.208 | 174.710▲ |
BBANDS | $HROW Bollinger Bands Expanding | Set Alert |
Friday, September 26, 2025 06:12 AM
Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company ...
|
Friday, September 26, 2025 04:58 AM
Harrow plans to submit a New Drug Application (“NDA”) to the FDA in 2027, with a potential U.S. commercial launch in 2028.
|
Friday, September 26, 2025 04:10 AM
Harrow (HROW) to acquire Melt Pharmaceuticals, a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for medical procedures in the hospital, outpatient, and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 48.74 | 48.89 | 46.45 | 48.18 | 819,700 |
29/09/25 | 49.54 | 50.39 | 47.32 | 48.40 | 1,242,400 |
26/09/25 | 46.29 | 50.72 | 46.29 | 47.10 | 1,324,800 |
25/09/25 | 47.50 | 47.96 | 46.00 | 46.15 | 750,800 |
24/09/25 | 48.50 | 49.24 | 47.51 | 47.88 | 496,600 |
23/09/25 | 47.33 | 50.19 | 47.32 | 48.85 | 879,200 |
22/09/25 | 43.95 | 46.42 | 43.50 | 46.09 | 650,900 |
19/09/25 | 45.77 | 45.86 | 43.65 | 44.34 | 756,200 |
18/09/25 | 43.65 | 45.50 | 43.50 | 45.38 | 888,000 |
17/09/25 | 42.90 | 43.85 | 42.23 | 43.15 | 611,100 |
|
|
||||
|
|
||||
|
|